{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:42:09Z","timestamp":1789749729742,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00702-008-0046-3","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T09:56:26Z","timestamp":1206957386000},"page":"1485-1494","source":"Crossref","is-referenced-by-count":38,"title":["Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model"],"prefix":"10.1007","volume":"115","author":[{"given":"Jarogniew J.","family":"Luszczki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigiusz","family":"Czernecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wojtal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga K.","family":"Borowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(00)02517-8","volume":"872","author":"K Abe","year":"2000","unstructured":"Abe K, Abe Y, Saito H (2000) Agmatine suppresses nitric oxide production in microglia. Brain Res 872:141\u2013148","journal-title":"Brain Res"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/nlme.2002.4076","volume":"78","author":"NS Arteni","year":"2002","unstructured":"Arteni NS, Lavinsky D, Rodrigues AL, Frison VB, Netto CA (2002) Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem 78:465\u2013469","journal-title":"Neurobiol Learn Mem"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.69.285","volume":"69","author":"M Auguet","year":"1995","unstructured":"Auguet M, Viossat I, Marin JG, Chabrier PE (1995) Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 69:285\u2013287","journal-title":"Jpn J Pharmacol"},{"key":"46_CR4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-3057(02)01079-1","volume":"74","author":"AK Bence","year":"2003","unstructured":"Bence AK, Worthen DR, Stables JP, Crooks PA (2003) An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Pharmacol Biochem Behav 74:771\u2013775","journal-title":"Pharmacol Biochem Behav"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","volume":"3","author":"JR Boissier","year":"1960","unstructured":"Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle m\u00e9thode simple pour explorer l\u2019action tranquilisante: le test de la chemin\u00e9e. Med Exp (Basel) 3:81\u201384","journal-title":"Med Exp (Basel)"},{"key":"46_CR6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1528-1157.1996.tb00625.x","volume":"37","author":"KK Borowicz","year":"1996","unstructured":"Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ (1996) Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia 37:618\u2013624","journal-title":"Epilepsia"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(97)01034-0","volume":"331","author":"KK Borowicz","year":"1997","unstructured":"Borowicz KK, Kleinrok Z, Czuczwar SJ (1997) Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur J Pharmacol 331:127\u2013132","journal-title":"Eur J Pharmacol"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007020050033","volume":"105","author":"KK Borowicz","year":"1998","unstructured":"Borowicz KK, Starownik R, Kleinrok Z, Czuczwar SJ (1998) The influence of l-NG-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J Neural Transm 105:1\u201312","journal-title":"J Neural Transm"},{"key":"46_CR9","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1073\/pnas.86.22.9030","volume":"86","author":"DS Bredt","year":"1989","unstructured":"Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030\u20139033","journal-title":"Proc Natl Acad Sci USA"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","volume":"6","author":"MJ Brodie","year":"1997","unstructured":"Brodie MJ, Dichter MA (1997) Established antiepileptic drugs. Seizure 6:159\u2013174","journal-title":"Seizure"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","volume":"5","author":"P Czapinski","year":"2005","unstructured":"Czapinski P, Blaszczyk B, Czuczwar SJ (2005) Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5:3\u201314","journal-title":"Curr Top Med Chem"},{"key":"46_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/mol.59.1.24","volume":"59","author":"DR Demady","year":"2001","unstructured":"Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa Y (2001) Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 59:24\u201329","journal-title":"Mol Pharmacol"},{"key":"46_CR13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0028-3908(03)00199-0","volume":"45","author":"S Demehri","year":"2003","unstructured":"Demehri S, Homayoun H, Honar H, Riazi K, Vafaie K, Roushanzamir F, Dehpour AR (2003) Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide. Neuropharmacology 45:534\u2013542","journal-title":"Neuropharmacology"},{"key":"46_CR14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0306-3623(98)00249-3","volume":"32","author":"A Denizbasi","year":"1999","unstructured":"Denizbasi A, Berkman K, Ozyazgan S, Eskazan E (1999) The effect of tizanidine on maximal electroshock seizures (MES) in mice. Gen Pharmacol 32:513\u2013516. Erratum in: (2000) Gen Pharmacol 34:443","journal-title":"Gen Pharmacol"},{"key":"46_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3160247","volume":"316","author":"E Galea","year":"1996","unstructured":"Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ (1996) Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 316:247\u2013249","journal-title":"Biochem J"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/336385a0","volume":"336","author":"J Garthwaite","year":"1988","unstructured":"Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385\u2013388","journal-title":"Nature"},{"key":"46_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(02)03198-0","volume":"952","author":"DA Gibson","year":"2002","unstructured":"Gibson DA, Harris BR, Rogers DT, Littleton JM (2002) Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res 952:71\u201377","journal-title":"Brain Res"},{"key":"46_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01625-6","volume":"296","author":"GM Gilad","year":"2000","unstructured":"Gilad GM, Gilad VH (2000) Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 296:97\u2013100","journal-title":"Neurosci Lett"},{"key":"46_CR19","first-page":"PL41","volume":"58","author":"GM Gilad","year":"1996","unstructured":"Gilad GM, Salame K, Rabey JM, Gilad VH (1996) Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 58:PL41\u2013PL46","journal-title":"Life Sci"},{"key":"46_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1476-5381.1996.tb15726.x","volume":"119","author":"C Gonzalez","year":"1996","unstructured":"Gonzalez C, Regunathan S, Reis DJ, Estrada C (1996) Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br J Pharmacol 119:677\u2013684","journal-title":"Br J Pharmacol"},{"key":"46_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0079-6123(08)61215-7","volume":"106","author":"A Holt","year":"1995","unstructured":"Holt A, Baker GB (1995) Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog Brain Res 106:187\u2013197","journal-title":"Prog Brain Res"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1152\/jn.1997.77.6.3355","volume":"77","author":"M Isokawa","year":"1997","unstructured":"Isokawa M, Levesque M, Fried I, Engel J Jr (1997) Glutamate currents in morphologically identified human dentate granule cells in temporal lobe epilepsy. J Neurophysiol 77:3355\u20133369","journal-title":"J Neurophysiol"},{"key":"46_CR23","first-page":"124","volume":"252","author":"SK Kulkarni","year":"1981","unstructured":"Kulkarni SK (1981) Actions of clonidine on convulsions and behaviour. Arch Int Pharmacodyn Ther 252:124\u2013132","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"46_CR24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","volume":"45","author":"P Kwan","year":"2004","unstructured":"Kwan P, Brodie MJ (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45:1141\u20131149","journal-title":"Epilepsia"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-4328(02)00326-1","volume":"141","author":"D Lavinsky","year":"2003","unstructured":"Lavinsky D, Arteni NS, Netto CA (2003) Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav Brain Res 141:19\u201324","journal-title":"Behav Brain Res"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966\u2013969","journal-title":"Science"},{"key":"46_CR27","first-page":"99","volume":"96","author":"JT Litchfield","year":"1949","unstructured":"Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose\u2013effect experiments. J Pharmacol Exp Ther 96:99\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0301-0082(97)00092-0","volume":"54","author":"W L\u00f6scher","year":"1998","unstructured":"L\u00f6scher W (1998) Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol 54:721\u2013741","journal-title":"Prog Neurobiol"},{"key":"46_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W (2002) Basic pharmacology of valproate: a review after 35\u00a0years of clinical use for the treatment of epilepsy. CNS Drugs 16:669\u2013694","journal-title":"CNS Drugs"},{"key":"46_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","volume":"8","author":"W L\u00f6scher","year":"1991","unstructured":"L\u00f6scher W, Fassbender CP, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8:79\u201394","journal-title":"Epilepsy Res"},{"key":"46_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pnpbp.2006.11.020","volume":"31","author":"JJ Luszczki","year":"2007","unstructured":"Luszczki JJ, Czuczwar SJ (2007) Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 31:529\u2013538","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"46_CR38","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","volume":"28","author":"JJ Luszczki","year":"2003","unstructured":"Luszczki JJ, Swiader M, Parada-Turska J, Czuczwar SJ (2003) Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology 28:1817\u20131830","journal-title":"Neuropsychopharmacology"},{"key":"46_CR39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","volume":"30","author":"JJ Luszczki","year":"2005","unstructured":"Luszczki JJ, Wojcik-Cwikla J, Andres MM, Czuczwar SJ (2005) Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 30:958\u2013973","journal-title":"Neuropsychopharmacology"},{"key":"46_CR32","first-page":"955","volume":"58","author":"JJ Luszczki","year":"2006","unstructured":"Luszczki JJ, Czuczwar M, Gawlik P, Sawiniec-P\u00f3\u017aniak G, Czuczwar K, Sawicka KM, Dudra-Jastrzebska M, Czuczwar SJ (2006a) Influence of NG-nitro-l-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep 58:955\u2013960","journal-title":"Pharmacol Rep"},{"key":"46_CR36","first-page":"660","volume":"58","author":"JJ Luszczki","year":"2006","unstructured":"Luszczki JJ, Sacharuk A, Wojciechowska A, Andres-Mach MM, Dudra-Jastrzebska M, Mohamed M, Sawicka KM, Kozinska J, Czuczwar SJ (2006b) 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 58:660\u2013671","journal-title":"Pharmacol Rep"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00702-005-0417-y","volume":"113","author":"JJ Luszczki","year":"2006","unstructured":"Luszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Pozniak G, Czuczwar K, Czuczwar SJ (2006c) 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm 113:1157\u20131168","journal-title":"J Neural Transm"},{"key":"46_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","volume":"373","author":"JJ Luszczki","year":"2006","unstructured":"Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ (2006d) Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn Schmiedebergs Arch Pharmacol 373:169\u2013181","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"46_CR37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eplepsyres.2007.06.010","volume":"76","author":"JJ Luszczki","year":"2007","unstructured":"Luszczki JJ, Sawicka KM, Kozinska J, Borowicz KK, Czuczwar SJ (2007a) Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model. Epilepsy Res 76:66\u201372","journal-title":"Epilepsy Res"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00702-007-0795-4","volume":"114","author":"JJ Luszczki","year":"2007","unstructured":"Luszczki JJ, Jankiewicz K, Jankiewicz M, Czuczwar SJ (2007b) Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model. J Neural Transm 114:1539\u20131545","journal-title":"J Neural Transm"},{"issue":"4S Suppl","key":"46_CR40","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","volume":"130","author":"BS Meldrum","year":"2000","unstructured":"Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130(4S Suppl):1007S\u20131015S","journal-title":"J Nutr"},{"key":"46_CR41","first-page":"51","volume":"109","author":"JJ Morrissey","year":"1997","unstructured":"Morrissey JJ, Klahr S (1997) Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians 109:51\u201357","journal-title":"Proc Assoc Am Physicians"},{"key":"46_CR42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","volume":"127","author":"G Olmos","year":"1999","unstructured":"Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpcio Boronat M, Trullas R, Villarroel A, Lerma J, Garc\u00eda-Sevilla JA (1999) Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127:1317\u20131326","journal-title":"Br J Pharmacol"},{"key":"46_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90613-M","volume":"250","author":"T Pietrasiewicz","year":"1993","unstructured":"Pietrasiewicz T, Czechowska G, Dziki M, Turski WA, Kleinrok Z, Czuczwar SJ (1993) Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics. Eur J Pharmacol 250:1\u20137","journal-title":"Eur J Pharmacol"},{"key":"46_CR44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1304.007","volume":"1009","author":"JE Piletz","year":"2003","unstructured":"Piletz JE, May PJ, Wang G, Zhu H (2003) Agmatine crosses the blood\u2013brain barrier. Ann N Y Acad Sci 1009:64\u201374","journal-title":"Ann N Y Acad Sci"},{"key":"46_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3940(96)13180-3","volume":"219","author":"J Pineda","year":"1996","unstructured":"Pineda J, Ruiz-Ortega JA, Mart\u00edn-Ruiz R, Ugedo L (1996) Agmatine does not have activity at alpha 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat. Neurosci Lett 219:103\u2013106","journal-title":"Neurosci Lett"},{"key":"46_CR46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00169058","volume":"351","author":"D Pinthong","year":"1995","unstructured":"Pinthong D, Wright IK, Hanmer C, Millns P, Mason R, Kendall DA, Wilson VG (1995) Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 351:10\u201316","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"46_CR47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","volume":"133","author":"W Raasch","year":"2001","unstructured":"Raasch W, Sch\u00e4fer U, Chun J, Dominiak P (2001) Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol 133:755\u2013780","journal-title":"Br J Pharmacol"},{"key":"46_CR48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","volume":"21","author":"DJ Reis","year":"2000","unstructured":"Reis DJ, Regunathan S (2000) Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187\u2013193","journal-title":"Trends Pharmacol Sci"},{"key":"46_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eplepsyres.2005.04.003","volume":"65","author":"K Riazi","year":"2005","unstructured":"Riazi K, Honar H, Homayoun H, Rashidi N, Kiani S, Ebrahimkhani MR, Noorian AR, Ghaffari K, Jannati A, Dehpour AR (2005) The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res 65:33\u201340","journal-title":"Epilepsy Res"},{"key":"46_CR50","first-page":"223","volume":"42","author":"MA Rogawski","year":"1990","unstructured":"Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223\u2013286","journal-title":"Pharmacol Rev"},{"key":"46_CR51","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1046\/j.1471-4159.1996.67041761.x","volume":"67","author":"M Sastre","year":"1996","unstructured":"Sastre M, Regunathan S, Galea E, Reis DJ (1996) Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem 67:1761\u20131765","journal-title":"J Neurochem"},{"key":"46_CR52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2003.11.016","volume":"77","author":"RB Su","year":"2004","unstructured":"Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J (2004) Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 77:345\u2013349","journal-title":"Pharmacol Biochem Behav"},{"key":"46_CR54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0361-9230(96)00159-1","volume":"41","author":"C Szabo","year":"1996","unstructured":"Szabo C (1996) Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 41:131\u2013141","journal-title":"Brain Res Bull"},{"key":"46_CR53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00233246","volume":"351","author":"B Szabo","year":"1995","unstructured":"Szabo B, Urban R, Limberger N, Starke K (1995) Cardiovascular effects of agmatine, a \u201cclonidine-displacing substance\u201d, in conscious rabbits. Naunyn Schmiedebergs Arch Pharmacol 351:268\u2013273","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"46_CR55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(91)90582-B","volume":"200","author":"E Urbanska","year":"1991","unstructured":"Urbanska E, Dziki M, Kleinrok Z, Czuczwar SJ, Turski WA (1991) Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur J Pharmacol 200:277\u2013282","journal-title":"Eur J Pharmacol"},{"key":"46_CR56","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","volume":"321","author":"P Venault","year":"1986","unstructured":"Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 321:864\u2013866","journal-title":"Nature"},{"key":"46_CR57","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1528-1157.1999.tb00818.x","volume":"40","author":"BR Walker","year":"1999","unstructured":"Walker BR, Easton A, Gale K (1999) Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40:1051\u20131057","journal-title":"Epilepsia"},{"key":"46_CR58","first-page":"746","volume":"24","author":"XC Weng","year":"2003","unstructured":"Weng XC, Gai XD, Zheng JQ, Li J (2003) Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin 24:746\u2013750","journal-title":"Acta Pharmacol Sin"},{"key":"46_CR59","first-page":"544","volume":"288","author":"XC Yang","year":"1999","unstructured":"Yang XC, Reis DJ (1999) Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288:544\u2013549","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0028-3908(94)90166-X","volume":"33","author":"T Zarnowski","year":"1994","unstructured":"Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1994a) The competitive NMDA antagonist, d-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology 33:619\u2013624","journal-title":"Neuropharmacology"},{"key":"46_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01277958","volume":"97","author":"T Zarnowski","year":"1994","unstructured":"Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1994b) The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice. J Neural Transm Gen Sect 97:1\u201312","journal-title":"J Neural Transm Gen Sect"},{"key":"46_CR62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","volume":"13","author":"AD Zomkowski","year":"2002","unstructured":"Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL (2002) Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13:387\u2013391","journal-title":"Neuroreport"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0046-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:25:09Z","timestamp":1559103909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0046-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}